medigraphic.com
Revista Médica Sinergia

2020, Number 06

<< Back Next >>

Revista Médica Sinergia 2020; 5 (06)

Cholangiocarcinoma approach

D’Alaimo BN, D’Avanzo ZD, Mora MKV

Language: Spanish
References: 16
Page: 1-11
PDF size: 164.66 Kb.


ABSTRACT

Cholangiocarcinoma is a relatively rare malignant neoplasm that arises from the bile duct epithelium. It can be classified according to its anatomical distribution as intrahepatic or extrahepatic. Geographical variations in the incidence of cholangiocarcinoma are related to variations in risk factors, the main ones being viral hepatitis, cirrhosis, primary sclerosing cholangitis and cholelithiasis. Despite the differences in the location of cholangiocarcinoma, it is associated with a poor prognosis and it is surgical resection that offers the best chance of cure. Therapeutic resistance is influenced by the rich tumor microenvironment and genetic heterogeneity characteristic of cholangiocarcinoma. Those patients with unresectable disease are still considered incurable.


REFERENCES

  1. Krasinskas A. Cholangiocarcinoma. Surg Pathol Clin. [Internet]. 2018 [citado en diciembre 2019];11(2):403-429. https://doi.org/10.1016/j.path.2018.02.005

  2. Oliveira I, Kilcoyne A, Everett J, Mino-Kenudson M, Harisinghani M, Ganesan K. Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management. Abdom Radiol (NY). [Internet]. 2017 [citado en diciembre 2019];42(6):1637-1649.https://doi.org/10.1007/s00261-017-1094-7

  3. Khan AS, Dageforde LA. Cholangiocarcinoma. Surgical Clinics of North America. 2019 04;99(2):315-335. https://doi.org/10.1016/j.suc.2018.12.004

  4. Doherty B, Nambudiri V, Palmer W. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Curr Gastroenterol Rep. [Internet]. 2017 [citado en diciembre 2019];19(1):1-8.https://doi.org/10.1007/s11894-017- 0542-4

  5. Razumilava N, Gores G. Cholangiocarcinoma. Lancet Gastroenterol Hepatol. [Internet]. 2014 [citado en diciembre 2019]; 383: 1-12.https://doi.org/10.1016/S0140-6736(13)61903-0

  6. Ho J, Curley S. Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer Treat Res. [Internet]. 2016 [citado en diciembre 2019];121-163.https://doi.org/10.1007/978-3-319-34244-3_7

  7. Rizvi S, Gores G. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Clin Gastroenterol Hepatol. [Internet]. 2013 [citado en diciembre 2019]; 145 (6): 1215 1229. https://doi.org/10.1053/j.gastro.2013.10.013

  8. Michael W. Mulholland, Keith D. Lillemoe, Gerard Doherty, Gilbert R.Upchurch, Jr., Hasan B. Alam, Timothy M. Pawlik ; illustrations by Holly R. Fischer Greenfield's surgery : scientific principles and practice. Vol 1. 6ta ed. Philadelphia: Wolters Kluwer; 2017

  9. Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th edition. New York: Springer; 2017.

  10. Byrling J, Andersson B, Andersson R, Marko-Varga G. Cholangiocarcinoma - Current Classification and Challenges Towards Personalized Medicine. Scand J Gastroenterol. [Internet]. 2016. [citado en diciembre 2019]; 51(6): 641-643. https://doi.org/10.3109/00365521.2015.1127409

  11. Bartella I, Dufour J. Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma. J Gastrointestin Liver Dis. [Internet]. 2015. [citado en diciembre 2019]; 24(4):481-489.https://doi.org/10.15403/jgld.2014.1121.244.chl

  12. Blechacz B, Ghouri Y, Mian I. Cancer review: Cholangiocarcinoma. J Carcinog. [Internet]. 2015. [citado en diciembre 2019];14(1):1-12. https://doi.org/10.4103/1477-3163.151940

  13. Ni T, Shang X, Wang W, Hu X, Zeng M, Rao S. Different MR features for differentiation of intrahepatic massforming cholangiocarcinoma from hepatocellular carcinoma according to tumor size. Br J Radiol. [Internet]. 2018 [citado en enero 2020]; 91 (1088): 1-8.https://doi.org/10.1259/bjr.20180017

  14. Courtney M. Townsend, Jr, R. Daniel Beauchamp, B. Mark Evers, Kenneth L. Mattox. Sabiston textbook of surgery: the biological basis of modern surgical practice. Vol 1. 20va ed. Philadelphia: Elsevier; 2017.

  15. Buettner S, Spolverato G, Kimbrough C, Alexandrescu S, Marques H, Lamelas J et al. The impact of neutrophilto- lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery. [Internet]. 2018 [citado enero 2020];164(3):411-418.https://doi.org/10.1016/j.surg.2018.05.002

  16. Conci S, Ruzzenente A, Viganò L, Ercolani G, Fontana A, Bagante F et al. Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic. Cholangiocarcinoma: Prognostic Impact After Surgery. Ann Surg Oncol. [Internet]. 2018. [citado enero 2020];25(12):3719-3727.https://doi.org/10.1245/s10434-018- 6669-1




2020     |     www.medigraphic.com